DLA Piper – The United States Food and Drug Administration (FDA) has released updated cybersecurity guidance titled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions – Guidance for Industry and Food and Drug Administration Staff (Guidance), reflecting the agency’s response to the growing integration of wireless and network connected capabilities in medical devices, which has made cybersecurity controls central to device safety and effectiveness.
Cybersecurity, Privacy, & AI
Trending Now
Weaponized Email AI Assistants Could Help Attackers Hijack Accounts • CISA Guidance Targets Water Sector Security, Open Source AI and More • Salesforce Previews Plans to Deliver Newly Authorized ‘AI Agents’ Across DOD • CMS Pivots to Risk-Based Cybersecurity Model, CISO Says • A New Framework for AI Data Center Security: NIST SP 800-239
FDA Issues Revised Cybersecurity Premarket Submission Guidance to Align With Quality Management System Regulation
bangoland | Shutterstock
Stay compliant and protected with daily updates on cybersecurity, data privacy, and federal oversight with our Cyber & Privacy newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.